Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Inhibitex Starts Veronate Hospital Infection Phase III Trial In Infants

July 1, 2004

By Aaron Lorenzo

Medarex Paying $4.7M To Acquire Ability Biomedical

June 28, 2004

By Aaron Lorenzo

Medarex Paying $4.7M To Acquire Ability Biomedical

June 28, 2004

By Aaron Lorenzo

Generex Receiving $30M Via Sejong Oralin Licensing Deal

June 25, 2004

By Aaron Lorenzo

Generex Receiving $30M Via Sejong Oralin Licensing Deal

June 25, 2004

By Aaron Lorenzo

Kosan, Roche Stop Colorectal Cancer Trial, Shift To Prostate

June 24, 2004

By Aaron Lorenzo

Kosan, Roche Stop Colorectal Cancer Trial, Shift To Prostate

June 24, 2004

By Aaron Lorenzo

Merix, Kirin Collaborating For Personalized Vaccine Products

June 23, 2004

By Aaron Lorenzo

Taste Technology Firm Senomyx Goes Public With $36M Offering

June 23, 2004

By Aaron Lorenzo

Merix, Kirin Collaborating For Personalized Vaccine Products

June 23, 2004

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...